Context Therapeutics Inc.
Context Therapeutics Inc.（CNTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cntx · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$5.25
+207.0% upside
Low
$4.50
Median: $5.25 · Last Close: $1.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$5.25
207.0% upside
High Target
$6
250.9%
Low Target
$4.5
163.2%
Current Price
$1.71
as of today
Based on analyst price targets, the CNTX stock price prediction for the next 12 months ranges from $4.5 to $6. The consensus CNTX price forecast of $5.25 implies 207.0% upside from the current price of $1.71.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.62 | ↓ 5.00% |
1-day model range: $1.61–$1.64. Peak: $1.64 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -32.7% |
| 2028 | $1 | -43.7% |
| 2029 | $1 | -48.3% |
| 2030 | $1 | -50.4% |
| 2031 | — | -51.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CNTX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-24 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-24 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-06 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-10-16 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-07 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-26 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-05-08 | D. Boral Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Context Therapeutics Inc. (CNTX) stock. Of the recent 27 rating actions, 1 were upgrades and 1 were downgrades. 6 analysts currently cover CNTX.
分析师推荐趋势
CNTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2M
↓ 18.4% YoY
Revenue Next Year
$0M
↓ 100.0% YoY
EPS This Year
$-0.39
EPS Next Year
$-0.41
↑ 4.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CNTX EPS of $-0.39 for the current fiscal year, based on estimates from 7 analysts. The CNTX revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CNTX 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CNTX 的共识目标价为 $5.25（+207.0% 上行空间），分析师共识为 Buy。
CNTX 的短期预测（明日）为 $1.62（-5.00%）。 CNTX 对 2027 年的股价预测均值为 $1。 CNTX 对 2030 年的预测区间为 $1–$1。
Context Therapeutics Inc. 在 NASDAQ 上市，代码 CNTX。CNTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
CNTX 预测 · 8 个问题根据 6 位华尔街分析师，CNTX 的 12 个月平均目标价为 $5.25，最高 $6.00、最低 $4.50。若有图表，中位目标价可在上方查看。相对当前价 $1.71，隐含约 +207.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.